“…A critical gap in the application of this approach is the availability of validated gene expression signatures that can be used to predict a chemical's mode of action, or the probability that the chemical induces specific toxicities, that have been robustly tested across laboratories, cell culture models (including human models), gene expression platforms, and experimental designs. Although many studies have published transcriptional signatures to predict various toxicities [Uehara et al, ; Minowa et al, ; Cheng et al, ; Doktorova et al, ; Eichner et al, ; Thomas et al, ; Yamada et al, ; Melis et al, ; Romer et al, ; Sahini et al, ; Wei et al, ; Oshida et al, ; Schmeits et al, ; Shen et al, ], these have not been extensively validated or applied, and the majority of this work has been done on rodent cells or tissues. Therefore, accepted signatures capturing diverse toxicological targets and effects in human cells are needed for development of effective chemical screening approaches.…”